Immunopharmacol Immunotoxicol

ISSN	1532-2513
ISSN-L	-
IUID	35e2c45c108646adbf340f33024029a4
Modified	2020-12-10T12:20:35.606Z
Created	2020-12-10T12:20:35.606Z

Year 2017

PubMed DOI Crossref

The anticancer effect of mebendazole may be due to M1 monocyte/macrophage activation via ERK1/2 and TLR8-dependent inflammasome activation.

Blom K, Senkowski W, Jarvius M, ..., Nygren P, Larsson R

Immunopharmacol Immunotoxicol 39 (4) 199-210 [2017-08-00; online 2017-05-04]

Drug Discovery and Development (DDD) [Service]

SciLifeLab Data Centre

Publications 9.5.0